Kaposi sarcoma in HIV patient. Case report

Authors

  • Eida Ortíz Zayas Departamento de Semiología. Facultad de Salud Pública. Escuela Superior Politécnica de Chimborazo. Panamericana Sur Km 1 ½. Chimborazo. Ecuador. EC060155
  • Mónica Yambay Latta Departamento de Anatomía Patológica. Hospital Provincial General Docente Riobamba. Avenida Juan Félix Proaño y Chile. Chimborazo. Ecuador. EC060111
  • Rolando Teruel Ginés Departamento de Medicina Interna II. Facultad de Salud Pública. Escuela Superior Politécnica de Chimborazo. Panamericana Sur Km 1 ½. Chimborazo. Ecuador. EC060155
  • María de los Ángeles Leyva Montero Departamento de Patología Humana. Facultad de Salud Pública. Escuela Superior Politécnica de Chimborazo. Panamericana Sur Km 1 ½. Chimborazo. Ecuador. EC060155
  • Rubén Andrés Ullauri Carballo Carrera de Medicina. Facultad de Salud Pública. Escuela Superior Politécnica de Chimborazo. Panamericana Sur Km 1 ½. Chimborazo. Ecuador. EC060155

DOI:

https://doi.org/10.47187/cssn.Vol15.IssEd.Esp.294

Keywords:

HIV, AIDS, Kaposi's sarcoma, immunodeficiency

Abstract

Introduction: Human Immunodeficiency Virus infection was identified as the causal agent of Acquired Immune Deficiency Syndrome in the 1980s. The natural development of this infection causes a progressive deterioration of immunity in the patient, mainly due to lysis. of CD4+ lymphocytes, leading the patient to profound immunosuppression that predisposes them to developing opportunistic infections, neurological disorders and malignant neoplasms. Case presentation: A case of a patient with Kaposi sarcoma in the latent clinical stage of HIV infection is presented, which constitutes an atypical behavior of the disease. The diagnosis of the case was confirmed by incisional biopsy and the patient was subjected to the treatment protocol established for these cases, with an adequate response to the antiretroviral therapy treatment and referred for care in a tertiary center for his oncological pathology. Conclusions: A case of HIV infection is presented that, despite maintaining the quantitative parameters of CD4+ count and viral load compatible with a latent clinical stage of the disease, develops a Kaposi sarcoma, having an atypical behavior of the underlying pathology.

Downloads

Download data is not yet available.

References

Alluhaybi AF, Hatatah NM. HIV-Associated Cutaneous Kaposi's Sarcoma. Cureus. 2021 Feb 24;13(2):e13544. doi: 10.7759/cureus.13544. PMID: 33654644; PMCID: PMC7905740.

Motlhale M, Sitas F, Bradshaw D, et al. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa. Cancer Epidemiol. 2022; 78:102167.

Santiago JC, Goldman JD, Zhao H, et al. Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma. PLoS Pathog. 2021; 17:e1008594.

Sabourin KR, Daud I, Ogolla S, et al. Malaria is associated with Kaposi sarcoma-associated herpesvirus seroconversion in a cohort of Western Kenyan children. J Infect Dis. 2021; 224: 303-311.

Liu Z, Fang Q, Zuo J, Minhas V, Wood C, Zhang T. The world-wide incidence of Kaposi's sarcoma in the HIV/AIDS era. HIV Med. 2018;19:355–364.

Luo Q, Satcher Johnson A, Hall HI, Cahoon EK, Shiels M. Kaposi sarcoma rates among persons living with human immunodeficiency virus in the United States: 2008–2016. Clin Infect Dis. 2020; 73: e2226–e2233.

Palich R, Veyri M, Valantin MA, Marcelin AG, Guihot A, Pourcher V, et al. Recurrence and occurrence of Kaposi’s sarcoma in patients living with human immunodeficiency virus (HIV) and on antiretroviral therapy, despite suppressed HIV viremia. Clin Infect Dis. 2020; 70: 2435–2438.

Caby F, Guiguet M, Weiss L, Winston A, Miro JM, Konopnicki D, et al. CD4/CD8 ratio and the risk of Kaposi sarcoma or non-Hodgkin lymphoma in the context of efficiently treated human immunodeficiency virus (HIV) infection: A collaborative analysis of 20 European cohort studies. Clin Infect Dis. 2020; 73: 50–59.

Lebbe C, Garbe C, Stratigos AJ, et al. Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer. 2019 Jun;114:117-127.

Etemad SA, Dewan AK. Kaposi Sarcoma Updates. Dermatol Clin. 2019 Oct;37(4):505-517.

Rullo V, Castellaneta F, D'Antonio S, De Rosa A, Grieco MP, Fabrizio T. Electrochemotherapy in Kaposi's Sarcoma Patients: From the Gold Standard Strategy to Locally Advanced Cutaneous and Subcutaneous Lesions. Cancers (Basel). 2024 Mar 27;16(7):1295. doi: 10.3390/cancers16071295. PMID: 38610972; PMCID: PMC11010848.

Palich R, Veyri M, Valantin MA, Marcelin AG, Guihot A, Pourcher V, Jary A, Solas C, Makinson A, Poizot-Martin I, et al. Recurrence and Occurrence of Kaposi’s Sarcoma in Patients Living with Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia. Clin Infect Dis. 2020;70:2435–2438.

Séverin D, Bessaoud F, Meftah N, Du Thanh A, Tretarre B, Guillot B, Makinson A. A comparative study of classic and HIV-viremic and aviremic AIDS Kaposi sarcoma. AIDS. 2020;35:399–405.

Caby F, Guiguet M, Weiss L, Winston A, Miro JM, Konopnicki D, Le Moing V, Bonnet F, Reiss P, Mussini C, et al. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies. Clin Infect Dis. 2020;73:50–59.

Benajiba L, Lambert J, La Selva R, Cochereau D, Baroudjian B, Roux J, Le Goff J, Pages C, Battistella M, Delyon J, et al. Systemic Treatment Initiation in Classical and Endemic Kaposi’s Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study. Cancers. 2021;13:2519.

Grabar S, Costagliola D. Epidemiology of Kaposi's Sarcoma. Cancers (Basel). 2021 Nov 14;13(22):5692. doi: 10.3390/cancers13225692. PMID: 34830846; PMCID: PMC8616388.

Blumenthal MJ, Schutz C, Barr D, Locketz M, Marshall V, Whitby D, Katz A, Uldrick T, Meintjes G, Schäfer G. The Contribution of Kaposi’s Sarcoma–Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus–Infected Patients Being Investigated for Tuberculosis in South Africa. J Infect Dis. 2019;220:841–851.

Dalla Pria A, Pinato DJ, Bracchi M, Bower M. Recent advances in HIV-associated Kaposi sarcoma. F1000Res. 2019 Jun 26;8:F1000 Faculty Rev-970. doi: 10.12688/f1000research.17401.1. PMID: 31297181; PMCID: PMC6600854.

Garcia-Bates TM, Palma ML, Shen C, et al. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions. J Virol. 2019;93(5):pii: e02035-18. doi: 10.1128/JVI.02035-18.

Fardhdiani V, Molfino L, Zamudio AG, Manuel R, Luciano G, Ciglenecki I, et al. HIV-associated Kaposi's sarcoma in Maputo, Mozambique: Outcomes in a specialized treatment center, 2010-2015. Infect Agent Cancer. 2018;13:5.

Chen TY, Yang HW, Lin DS, Huang ZD, Chang L. HIV fragments detected in Kaposi sarcoma tumor cells in HIV-infected patients. Medicine (Baltimore). 2022 Oct 28;101(43):e31310. doi: 10.1097/MD.0000000000031310. PMID: 36316837; PMCID: PMC9622637.

Kawakami N, Namkoong H, Shimoda M, et al. Hidden disseminated extracutaneous AIDS-related Kaposi sarcoma. IDCases. 2020;19:e00716.

Zhao CJ, Ma GZ, Wang YJ, et al. Splenic Kaposi’s sarcoma in a human immunodeficiency virus-negative patient: a case report. World J Clin Cases. 2021;9:4765–71.

Adams P, Vancutsem E, Nicolaizeau C, et al. Multicenter evaluation of the cobas(R) HIV-1 quantitative nucleic acid test for use on the cobas(R) 4800 system for the quantification of HIV-1 plasma viral load. J Clin Virol. 2019;114:43–9.

Salto JN, Volkow P, Herrera-Goepfert R, López-Garcia AI, Cortes-Garcia BY, García-Pérez FO, Arroyo-Hernandez M, Rivera-Rosales RM. Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS. AIDS. 2024 May 1;38(6):933-934. doi: 10.1097/QAD.0000000000003851. Epub 2024 Apr 4. PMID: 38578965.

Ibrahim Khalil A, Franceschi S, de Martel C, Bray F, Clifford GM. Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis. Int J Cancer. 2022 Jun 15;150(12):1948-1957. doi: 10.1002/ijc.33951. Epub 2022 Feb 16. PMID: 35085400.

Motlhale M, Sitas F, Bradshaw D, Chen WC, Singini MG, de Villiers CB, Lewis CM, Muchengeti M, Waterboer T, Mathew CG, Newton R, Singh E. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa. Cancer Epidemiol. 2022 Jun;78:102167. doi: 10.1016/j.canep.2022.102167. Epub 2022 Apr 30. PMID: 35504064.

Lambarey H, Blumenthal MJ, Chetram A, Joyimbana W, Jennings L, Orrell C, Schäfer G. Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients. EBioMedicine. 2024 Feb;100:104986. doi: 10.1016/j.ebiom.2024.104986. Epub 2024 Feb 2. PMID: 38306893; PMCID: PMC10850403.

Ngalamika O, Munsaka S, Lidenge SJ, West JT, Wood C. Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome. AIDS Res Hum Retroviruses. 2021 May;37(5):368-372. doi: 10.1089/AID.2020.0099. Epub 2021 Feb 2. PMID: 33386064; PMCID: PMC8112720.

Freeman EE, Busakhala N, Regan S, et al. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya. BMC Cancer. 2020;20:71.

Downloads

Published

2024-09-20

How to Cite

Ortíz Zayas , E., Yambay Latta , M., Teruel Ginés , R., Leyva Montero , M. de los Ángeles, & Ullauri Carballo , R. A. (2024). Kaposi sarcoma in HIV patient. Case report. LA CIENCIA AL SERVICIO DE LA SALUD Y NUTRICIÓN, 15(Ed. Esp.), A_7–12. https://doi.org/10.47187/cssn.Vol15.IssEd.Esp.294

Issue

Vol. 15 No. Ed. Esp. (2024): Edición Especial CIEM 2024

Section

Casos Clínicos

License

Copyright (c) 2024 LA CIENCIA AL SERVICIO DE LA SALUD Y NUTRICIÓN

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)

1 2 > >>